Elevated Red Cell Distribution Width Linked to Increased Mortality in Sepsis-Associated Liver Injury
- A retrospective study of 529 patients with sepsis-associated liver injury (SALI) found that elevated red cell distribution width (RDW) was prevalent in 46.1% of cases.
- Patients with higher RDW exhibited significantly increased 30-day mortality rates compared to those with lower RDW (17.2±3.0 vs. 15.4±2.3, P < 0.001).
- Multivariable Cox regression analysis identified RDW as an independent risk factor for 30-day mortality in SALI patients (HR 1.14, 95% CI 1.09 to 1.19, P < 0.001).
- The study suggests that RDW could serve as a valuable biomarker for risk stratification and clinical management in patients with SALI.
A recent study published in Frontiers in Medicine has revealed a significant association between elevated red cell distribution width (RDW) and increased 30-day mortality in patients with sepsis-associated liver injury (SALI). The retrospective cohort study, utilizing data from the Medical Information Mart for Intensive Care-IV database, highlights the potential of RDW as a biomarker for risk stratification in this vulnerable patient population.
The research, conducted by investigators at Beijing Luhe Hospital, Capital Medical University, included 529 patients admitted to the intensive care unit (ICU) with SALI. The study aimed to evaluate whether RDW, a measure of the variation in red blood cell volume, could predict mortality in these patients. Sepsis-associated liver injury is a critical complication of sepsis, contributing to multiple organ dysfunction and high mortality rates.
The study population had a mean age of 68.7 years, with 61.8% being male. Researchers found that 46.1% of the patients had an RDW greater than 15.5%. The 30-day mortality rate in the cohort was 35.5%. Notably, RDW was significantly higher in non-survivors compared to survivors (17.2±3.0 vs. 15.4±2.3, P < 0.001).
Multivariable Cox regression analysis confirmed that RDW was an independent risk factor for 30-day mortality (HR 1.14, 95% CI 1.09 to 1.19, P < 0.001). This finding suggests that even after adjusting for other potential confounding variables, RDW remains a significant predictor of mortality in SALI patients. Subgroup analyses further supported the consistency of these findings across various patient groups.
"Our findings indicate that elevated RDW is independently associated with higher 30-day mortality in patients with SALI," the authors stated. "This suggests its potential role in risk stratification and clinical management."
The study's results suggest that RDW, a readily available and inexpensive laboratory test, could be incorporated into clinical practice to identify SALI patients at higher risk of mortality. This could facilitate more aggressive monitoring and timely interventions, potentially improving patient outcomes.
The authors acknowledge that the study's retrospective design and reliance on a single database may limit the generalizability of the findings. Further prospective studies are needed to validate these results and explore the underlying mechanisms linking RDW to mortality in SALI.

Stay Updated with Our Daily Newsletter
Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.
Related Topics
Reference News
[1]
Association between Red Cell Distribution Width and 30-day mortality in patients with ... - Frontiers
frontiersin.org · Nov 29, 2024
Study evaluates RDW's association with 30-day mortality in SALI patients, finding RDW as an independent risk factor (HR ...